Statement Of Cash Flows [Abstract]
| Concept |
2023-01-01 to 2023-12-31 |
2022-01-01 to 2022-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for interest expense |
255,000
EUR
|
172,000
EUR
|
| Adjustments for interest income |
70,000
EUR
|
173,000
EUR
|
| Adjustments for deferred tax expense |
511,000
EUR
|
674,000
EUR
|
| Cash flows from (used in) operations before changes in working capital |
4,462
EUR
|
7,717
EUR
|
| Adjustments for decrease (increase) in other assets |
743,000
EUR
|
0
EUR
|
| Adjustments for increase (decrease) in other current liabilities |
706,000
EUR
|
407,000
EUR
|
| Adjustments for increase (decrease) in employee benefit liabilities |
98,000
EUR
|
38,000
EUR
|
| Adjustments for decrease (increase) in loans and advances | — | — |
| Adjustments for decrease (increase) in loans and advances to customers |
106,000
EUR
|
0
EUR
|
| Adjustments for decrease (increase) in biological assets |
204,000
EUR
|
921,000
EUR
|
| Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, property, plant and equipment |
0
EUR
|
1,636
EUR
|